http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5562007-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39ae96c0ecc22ff90ff986371a3cea0f
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-02
filingDate 1978-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59943f5bcccc4d17eb031e7ea46bab39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a585cd6259ac332635b157bc1352a0a1
publicationDate 1980-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S5562007-A
titleOfInvention Preparation for rectal administration
abstract PURPOSE: A preparation for rectal administration having improved absorption, comprising a slightly absorbable antibiotic, cholic acid, and a fatty acid glyceride. n CONSTITUTION: An antibiotic having poor absorption in oral administration, e.g. cefazolin, kanamycin, and erythromycin, is mixed with cholic acid or its salt and a fatty acid glyceride, e.g. a medium or higher fatty acid triglyceride. The composition thus obtained is formed into an anal suppository or a suspension or ointment, and filled into a rectal administration tube to give an easily absorbable preparation. n COPYRIGHT: (C)1980,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0263493-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013052010-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0211434-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4760059-A
priorityDate 1978-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425258636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33255
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487501
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395008
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12560
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395182
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID221493
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13296868
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420229795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395183
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66577477
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395009
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493484
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395099
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6604080
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411143462

Total number of triples: 33.